Sympathetic neural mechanisms in obstructive sleep apnea

V K Somers, M E Dyken, M P Clary, F M Abboud, V K Somers, M E Dyken, M P Clary, F M Abboud

Abstract

Blood pressure, heart rate, sympathetic nerve activity, and polysomnography were recorded during wakefulness and sleep in 10 patients with obstructive sleep apnea. Measurements were also obtained after treatment with continuous positive airway pressure (CPAP) in four patients. Awake sympathetic activity was also measured in 10 age- and sex-matched control subjects and in 5 obese subjects without a history of sleep apnea. Patients with sleep apnea had high levels of nerve activity even when awake (P < 0.001). Blood pressure and sympathetic nerve activity did not fall during any stage of sleep. Mean blood pressure was 92 +/- 4.5 mmHg when awake and reached peak levels of 116 +/- 5 and 127 +/- 7 mmHg during stage II sleep (n = 10) and rapid eye movement (REM) sleep (n = 5), respectively (P < 0.001). Sympathetic activity increased during sleep (P = 0.01) especially during stage II (133 +/- 9% above wakefulness; P = 0.006) and REM (141 +/- 13%; P = 0.007). Peak sympathetic activity (measured over the last 10 s of each apneic event) increased to 299 +/- 96% during stage II sleep and to 246 +/- 36% during REM sleep (both P < 0.001). CPAP decreased sympathetic activity and blood pressure during sleep (P < 0.03). We conclude that patients with obstructive sleep apnea have high sympathetic activity when awake, with further increases in blood pressure and sympathetic activity during sleep. These increases are attenuated by treatment with CPAP.

References

    1. N Engl J Med. 1990 Sep 13;323(11):693-9
    1. Neurology. 1991 Dec;41(12):1961-6
    1. J Clin Invest. 1991 Jun;87(6):1953-7
    1. Hypertension. 1991 Jun;17(6 Pt 2):1057-62
    1. Electroencephalogr Clin Neurophysiol. 1971 Sep;31(3):277-81
    1. Ann Intern Med. 1976 Dec;85(6):714-9
    1. J Physiol. 1977 Nov;272(2):383-97
    1. Ann Intern Med. 1978 Oct;89(4):454-8
    1. Acta Physiol Scand. 1981 Jan;111(1):69-73
    1. Chest. 1982 Jul;82(1):122-4
    1. Hypertension. 1984 Jul-Aug;6(4):557-62
    1. Am Heart J. 1984 Aug;108(2):373-6
    1. Acta Physiol Scand. 1984 Apr;120(4):499-504
    1. Lancet. 1984 Nov 3;2(8410):1005-8
    1. Lancet. 1985 Jan 12;1(8420):89-91
    1. Circ Res. 1985 Sep;57(3):461-9
    1. Chest. 1986 Mar;89(3):331-4
    1. Cardiovasc Res. 1986 Nov;20(11):853-62
    1. N Engl J Med. 1988 Apr 28;318(17):1077-83
    1. Am J Public Health. 1988 May;78(5):544-7
    1. Chest. 1988 Jul;94(1):9-14
    1. Hypertension. 1988 Jun;11(6 Pt 2):608-12
    1. J Hypertens Suppl. 1988 Dec;6(4):S529-31
    1. Clin Exp Hypertens A. 1988;10 Suppl 1:413-22
    1. Hypertension. 1989 Jun;13(6 Pt 1):647-55
    1. Hypertension. 1989 Jun;13(6 Pt 2):870-7
    1. Stroke. 1989 Oct;20(10):1311-5
    1. J Appl Physiol (1985). 1989 Nov;67(5):2095-100
    1. J Appl Physiol (1985). 1989 Nov;67(5):2101-6
    1. Brain. 1991 Jun;114 ( Pt 3):1281-95
    1. Lancet. 1991 Dec 14;338(8781):1480-4
    1. N Engl J Med. 1993 Feb 4;328(5):303-7
    1. J Physiol. 1992 Sep;455:219-33
    1. Am J Cardiol. 1993 Jun 1;71(15):1341-5
    1. J Auton Nerv Syst. 1993 Aug-Sep;44(2-3):253-9
    1. J Appl Physiol (1985). 1993 Oct;75(4):1439-43
    1. Electroencephalogr Clin Neurophysiol. 1957 Nov;9(4):673-90
    1. Mayo Clin Proc. 1990 Sep;65(9):1250-9

Source: PubMed

3
Iratkozz fel